FIELD: medicine, narcology. SUBSTANCE: invention proposes the use of narcotic antagonist nalmephen at daily dose 2.5-300.0 mg in combination with the use of alcoholic drink. EFFECT: enhanced therapeutic effectiveness of treatment. 4 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND OPIOMANIA | 2008 |
|
RU2393864C1 |
| COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ADDICTIONS | 2008 |
|
RU2492858C2 |
| ADMINISTRATION OF ATIPAMEZOLE FOR TREATING SEXUAL MALE IMPOTENCE | 1992 |
|
RU2111749C1 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES | 2014 |
|
RU2679661C1 |
| USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE | 2018 |
|
RU2806869C2 |
| METHOD OF TREATMENT OF ALCOHOLISM | 2017 |
|
RU2665629C1 |
| PERCUTANEOUS PREPARATION | 1993 |
|
RU2140785C1 |
| METHOD FOR TREATING THE CASES OF DRUG ADDICTION | 2003 |
|
RU2288717C2 |
| BUPRENORPHINE-CONTAINING ANALGESIC COMPOSITIONS | 2000 |
|
RU2255737C2 |
| BLOCKING AGENT OF WITHDRAWAL SYNDROME THAT IS A RESULT OF DRUG HABITUATION TO OVER INTAKING DRUGS AND SUBSTANCES CAUSING HABITUATION, PHARMACOLOGICAL COMPOSITION BASED ON THEREOF AND A METHOD OF RELIEF OR PREVENTION OF WITHDRAWAL SYNDROME | 1992 |
|
RU2095062C1 |
